Journal of

---

Background and Aim: Burns are among the most common causes of wounds. One of the medications used in these cases is silver sulfadiazine 1%, which has many side effects. Therefore, people turn to traditional compounds for treatment of these ulcers . Despite the widespread use of lime water in combination with olive oil and Ziziphus in Iran, little research has been done to prove their benefits. The purpose of this study was to investigate the topical effect of Ziziphus and olive oil and lime water combination on the healing rate of third-degree burns in mice.

Methods: In this study, 24 male Balb/c mice with a mean weight of 25±5 g were used. After anesthesia, a 1 cm² third-degree burn was created with a special device. The mice were randomly divided into four groups and received normal saline, Ziziphus poultice, olive oil-lime water, or silver sulfadiazine 1% daily. Pictures were taken weekly for three weeks. Then the area of the wounds was measured and the percentage of healing was calculated. Repeated measure ANOVA was used to analyze the data.

Results: In all weeks, the percentage of wound healing in the second to fourth groups was significantly higher than that of the first group, but was not significantly different from each other.

Conclusion: The results of this study showed the positive effect of Ziziphus leaves and the combination of olive oil and lime water on the healing rate of third-degree burn wounds in mice.

---

Background and Aim: Cutaneous leishmaniasis is one of the most important health problems in Iran. There is still no effective vaccine available against human leishmaniasis and current treatment is based on chemotherapy. Conventional drugs are toxic and expensive, and drug resistance has caused the search for new treatments. Tofacitinib is a Janus kinase inhibitor that disturbs the signaling pathway of several cytokines in the immune system. The aim of this study was to evalute the effect of topical tofacitinib 2% ointment in healing cutaneous leishmaniasis in Balb/C mice.
 

Methods: This experimental study was performed using tofacitinib and glucantim drugs in 40 female Balb/C mice. The metacyclic form of promastigote of Leishmania major standard strain (MRHO/IR/75/ER) was injected into the footpad of the mice, the mice were divided into 4 treatment groups: tofacitinib, glucantim, tofacitinib-glucantim and control without treatment. The treatment period was 28 days. The footpad thickness of all groups was measured at the end of each week.
 

Results: After the end of the treatment in the groups treated with tofacitinib, a significant decrease in the size of lesion and the footpad thickness was observed compared to the control group without treatment (P<0.01).
 

Conclusion: It seems that tofacitinib ointment accelerates lesion healing in Balb/C mice and has worked similarly to standard glucantim treatment. Ointment can be a better option for leishmaniasis treatment and due to its ease of use and no need for painful injections it can be considered as an option for the treatment of patients with cutaneous leishmaniasis.